Search
Now showing items 1-1 of 1
Learnings from real-life experience of using omalizumab for chronicurticaria in Latin America
(Elsevier, 2019-01-08)
Updated urticaria guidelines recommend that patients should be assessed for disease activity, severity,
control, and quality of life at baseline and follow up. Regarding treatment, guidelines consider second generation ...